"Edge in-situ heterogeneous" BiOI based on defect engineering and non-noble metal deposition: Boosting visible-light photocatalytic sterilization.

[Display omitted] • "Edge in-situ heterogeneous" BiOI was synthesized. • BB exhibited the structures of both iodine defects and in-situ bismuth deposition. • The visible-light utilization and charge separation efficiency of BiOI were enhanced. • BB displayed excellent bactericidal ability and wound healing performance. The inherent narrow band gap of bismuth oxyiodide (BiOI) consistently leads to the rapid recombination of photogenerated carriers, significantly constraining its practical utility. To combat this shortcoming, we devise a Bi/BiOI 1−x (BB) nanosheet with edge heterostructure. It is modified by the introduction of both iodine defects and in-situ bismuth deposition through high-temperature calcination and solvothermal strategy. Notably, the in-situ deposition of bismuth enhances the visible-light absorption ability of BiOI. And the incorporation of iodine defects initiates a modification in the band position of BiOI, ultimately diminishing the electron-hole recombination rate effectively. More importantly, facilitated by the major work function of bismuth, a Schottky barrier is formed at the BB heterojunction interface, which effectively promotes the separation of photogenerated charges within BB. And the photocurrent intensity of BB is 4 times higher than that of pure BiOI. These ingenious designs result in a significant boost in the generation of reactive oxygen species (ROS) through the accumulation of electrons and holes on the surfaces of both Bi and BiOI 1−x. And BB photocatalyst shows an outstanding broad-spectrum bactericidal performance. The antibacterial rates against Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) are 88.01% and 90.01%, respectively, which are increased by 80.6% and 83.8% compared with BiOI. Moreover, in vivo experiments provide compelling evidence for the BB photocatalyst's potential in promoting wound healing. The healing rate after BB treatment has already reached more than 95% on the fifth day. This work offers valuable insights on enhancing the sterilization performance of photocatalysts based on the synergistic effects of defect engineering and non-noble metal deposition. [ABSTRACT FROM AUTHOR]